This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Justin S. Bickford
Introduction
Justin S. Bickford is an accomplished inventor based in Gainesville, FL (US). He has made significant strides in the field of female reproductive health through his innovative research and development. His work primarily focuses on non-hormonal contraceptive methods, which aim to provide women with alternative options for fertility control.
Latest Patents
Bickford holds a patent for a non-hormonal female contraceptive. This patent discloses compositions and methods for controlling the fertility of a female subject. The compositions particularly exemplified include sugar derivatives such as 2-deoxyglucose, D-mannoheptulose, and/or 5-thio-D-glucose. Additionally, the patent outlines methods for preserving the ova supply in a female subject by administering glucose derivatives. The composition typically includes a glucose derivative that affects Foxo3a expression. He has 1 patent to his name.
Career Highlights
Justin S. Bickford is associated with the University of Florida Research Foundation Inc., where he continues to contribute to groundbreaking research in reproductive health. His work is characterized by a commitment to developing innovative solutions that address critical health issues faced by women.
Collaborations
Bickford has collaborated with notable colleagues, including Sarah J. Barilovits and Kimberly J. Aiken. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Justin S. Bickford's contributions to the field of female reproductive health through his innovative patent demonstrate his dedication to improving women's health options. His work continues to pave the way for future advancements in non-hormonal contraceptive methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
